Family with sequence similarity 98, member B pseudogene (ENSG00000271498)

Pseudogenes are genomic elements that share sequence similarity with protein-coding genes but have lost their ability to encode functional proteins, often due to disabling mutations or lack of necessary regulatory elements[1][3]. While once considered non-functional “junk DNA,” some pseudogenes are now recognized to produce noncoding RNAs that can impact gene regulation, commonly by functioning as decoys for microRNAs or, less commonly, by being processed into small interfering RNAs that regulate parental gene expression[1][3]. However, most annotated pseudogenes—including “family with sequence similarity 98, member B pseudogene”—lack evidence for direct involvement in biological processes or human disease, and are not considered drug targets[1][3]. There are no documented drugs, biomarkers, or safety issues associated with this pseudogene; its main relevance is as a component of the genome’s noncoding fraction involved in transcriptome complexity. If there is a legitimate Ensembl or gene database entry for this pseudogene, it serves as an annotated locus and not as a functional protein target for pharmacological intervention. Summary of Issues: - This entry is a pseudogene—there is no encoded protein, receptor, enzyme, or other conventional molecular target. - It is not considered a therapeutic target in drug discovery or clinical medicine. - No known biological, pathological, or biomarker role is established for this specific pseudogene. - Its presence is likely only of interest in studies of genome structure, evolution, or regulatory noncoding RNA biology. If you are seeking a druggable or disease-relevant target, this entry is not appropriate.

Other names

FAM98B pseudogenefamily with sequence similarity 98, member B, pseudogene